Location of Repository

Functional genetic variation of the vitamin D receptor in malignant melanoma and psoriasis

By John A. Halsall

Abstract

The vitamin D receptor (VDR) is the nuclear receptor for 1\alpha,25-dihydroxyvitamin D_3(1,25(OH)_2D_3), the active form of vitamin D. Classically involved in the regulation of calcium and phosphate homeostasis and bone mineralisation, 1,25(OH)_2D_3 has recently been demonstrated to suppress proliferation and promote differentiation in a number of cell types. This has led to the study of the 1,25(OH)_2D_3 pathway in malignancies such as melanoma and hyperproliferative disorders such as psoriasis.\ud Genetic variation of the VDR has previously been associated with prognosis in malignant melanoma and occurrence and treatment response in psoriasis.\ud Here, the major promoter region of the VDR, the 1a promoter region, was screened for variation. The novel polymorphism, A- 1012G, was discovered and was predicted to lie within a GATA-3 binding site, such that the site is only present in the case of the A allele. GATA-3 is a T-cell specific transcription factor involved in polarising the T-cell response to a type 2 (Th2) response and suppressing Th1 responses. It was hypothesised that the A allele would be a risk factor in malignant melanoma, due to decreased immunosurveillance but beneficial in psoriasis, due to a reduction in Th1-mediated inflammation and keratinocyte hyperproliferation.\ud The affect of this polymorphism was studied in 191 malignant melanoma patients, 206 psoriasis patients and 80 controls. AA genotype were associated with increased risk of both occurrence (P=0.015) and metastasis (P=0.008) in melanoma. The A allele was under-represented in psoriasis patients with no family history compared to those with a family history (P=0.01), and associated with response to the vitamin D analogue Dovonex (P=0.04).\ud GATA-3 was shown to bind at the A but not the G allele of A-1012G in gel-shift\ud assays. In vitro studies demonstrated that T cells with AA and AG genotypes were more sensitive to 1,25(OH)_2D_3 treatment than those with GG genotype

Publisher: University of Leicester
Year: 2005
OAI identifier: oai:lra.le.ac.uk:2381/7715

Suggested articles

Preview

Citations

  1. (2003). (eds) pp 817-823, Riverside- University of California Wong
  2. (2000). 2"ihydroxyvilmnin D3 Inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. doi
  3. (2003). 42 The International Psoriasis Genetics Study. Assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. doi
  4. (2002). A novel polymorphism of the VDR and psorlasis HaIsWl of A 355 31 Okita
  5. (1991). A unique mutation In the vitamin D receptor gene In three Japanese patients with vitamin D-deptrident rickets type I[: utility of single strand conformation polymorphism analysis for heterozygous carrier detection. Am I Hum Genet 49- 668-673 Schondorf
  6. (2001). acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natt Arad Sci USA 89,6665-6669 Osborne IF, Hutchinson PE
  7. Adequin: Software for Population Genetics Data Analysis, version
  8. at &I Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer &pidsmiol Biomarkers Prev 1997,6:
  9. (2004). at at Prediction of bone density from vitamin D receptor alleles.
  10. (2002). at at Vitamin D receptor genotypes are not associated with clinical response to calcipotriol in Korean psoriasis patients. Arch Dermatol Res doi
  11. (1999). BioloSy and Clinical Applications of the Steroid Hormone,
  12. (1996). Chen TCý Holick MF. Induction of vitamin D receptor mRNA expression in peoriatic plaques correlates with clinical response to 1,25-dihydroxpitamin D3. doi
  13. (2002). Cý Adorini L The coming of age of 1,2"ihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Mod
  14. (1980). Demonstration of 1,25-dihydroxyvitamin D3 receptors In human skin biopsies. doi
  15. (1999). di Giovine FS. Novel genetic association between the comeodesmosin (MHC S) gene and susceptibility to psoriasis. Hum Mol Genet
  16. (1996). Duijn CK of at A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Minot Res doi
  17. (2002). et aL Polyrnorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulagaris. doi
  18. (1997). Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (I 6q and 20p) by genome-wide scan. Hum Mot Genet doi
  19. (2001). Genetic Variation of the VDR ............................................................................
  20. Genornlcs 2005,15: 349-355 Keywords: psoriasis susceptibility. psoriasis treatment VDR VDR polymorphisms 'Department of Cancer Studies and Molecular Medicine,
  21. (2004). Gysomans Cý Bouillon R Overbergh L Vitamin D and 1,25-dihydroxyvitamin D3 as modulators In the immune system. doi
  22. (1991). Huq AH, Naito Eý Yokota I, of at A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin Ddependent rickets type 11: Utility of single strand conformation polymorphism analysis for heterozygous camer detection.
  23. (1997). Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet
  24. (1997). Koski-Oja I Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol. doi
  25. (1996). Kragballe K Normal levels of the vitamin 0 receptor and he message in psoriatic skin.
  26. (1985). Malignant melanoma In Scotland 1979-1983. doi
  27. (2004). Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p2l and 4q28-q3l in Caucasian and Chinese Hans population. doi
  28. (1959). Morphologic and physiological effects of chemotherapeutic agents in psoriasis.
  29. (2001). O'Garra A doi
  30. (1970). Observations on mitoses in psoriatic epidermis. doi
  31. (2000). of at A candidate gene for psoriasis near HLA-C, HCR (PgB), Is highly polymorphic with a diseawassocialed susceptibility allots. Hum Mol Genet
  32. (2001). Outcome in prostate cancer associations with skin type and polymorphism in pigmentation-related genes. doi
  33. (2000). Oza K Dang HTL, of at Are human vitamin D receptor gone polymorphisms functionally significant? In: doi
  34. (1985). Peofiasis of eady and late onset: characterization of two types of psoriasis vulgaris. doi
  35. (1983). Regulation of terminal differentiation of cultured mouse epidermal cello by I alpha, 25-clihydroxyvitamin D3. Endocrinology doi
  36. (2005). requests for reprints to
  37. (1996). Sanan DK Clinical uses for calcitropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective.
  38. (1996). Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. doi
  39. (1979). Target cells for 1,25-dihydroxyvitamin D3 in intestinal trac% stomach, kidney, skin, pituitary, and parathyroid. Science doi
  40. (1998). The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine, secretion and inhibits cytokines of the psoriatic cytokine network. doi
  41. (1999). The caudal-related homeodomain protein Cdx2 regulates vitamin D receptor gene expression in the small intestine. doi
  42. The genetics of psoirissis, psoriatic arthritis and atopic dermatitis.
  43. (1994). The genetics of psoriasis. Arch Dermatol
  44. (2000). Transcriptional regulation of Th I /Th2 polarization. Immurrol Today doi
  45. (2001). Treatment of peripheral blood mononuclear cells with 8-methoxypsomien plus ultraviolet A radiation induces a shift in cytokine expression from a Thl to a Th2 response. doi
  46. (2000). Vitamin D receptor as a candidate tumor-supprcssor gene in severe doi
  47. (1998). Vitamin D receptor polymorphism and calcipotriol response in patients with psoriasis. doi
  48. (1999). Vitamin D receptor polymorphism is associated with psoriasis. doi
  49. (1999). Vitamin D receptor polymorphiSM3 as markers in prostate cancer. doi
  50. (1998). Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer In United States physicians.
  51. (2001). Vitamin D: he role and uses In Immunology.
  52. (1998). Vitamin D3: a transcriptional modulator of the interferon-gamma gene. doi
  53. (1986). Walworth NCý Holick MR Effect of 1,25-dihydroxyvitamin 03 on the morphological and biochemical differentiation of cultured human epidermal keratinocytes grown in Berum-froo conditions.
  54. Zitzer K of al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor 1113. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.